Skip to content

Drug interactions

Lopinavir + Medroxyprogesterone

Severity: Moderate

Lopinavir and Medroxyprogesterone: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lopinavir, co-formulated with ritonavir, inhibits CYP3A4 and may increase medroxyprogesterone exposure. Increased progestin adverse effects are possible, although data are limited.

What this interaction means in plain words

Lopinavir and Medroxyprogesterone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lopinavir belongs to Anti Virals; Medroxyprogesterone belongs to Endocrine.

Evidence level: Low

Why it happens

Ritonavir-boosted lopinavir inhibits CYP3A4 metabolism of medroxyprogesterone.

What to do

Monitor for progestogenic adverse effects and glycemic changes. Adjust the hormonal regimen if tolerability is poor.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lopinavir and Medroxyprogesterone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Lopinavir with Medroxyprogesterone?

MediHelp rates the interaction as moderate. Lopinavir and Medroxyprogesterone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lopinavir, co-formulated with ritonavir, inhibits CYP3A4 and may increase medroxyprogesterone exposure. Increased progestin adverse effects are possible, although data are limited.

How serious is the interaction between Lopinavir and Medroxyprogesterone?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for progestogenic adverse effects and glycemic changes. Adjust the hormonal regimen if tolerability is poor.

What other medicines interact with Medroxyprogesterone?

MediHelp also lists interactions of Medroxyprogesterone with, for example, Bosentan, Brigatinib, Eslicarbazepine. The full list is on the Medroxyprogesterone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in